Investigating the Efficacy of a Paediatric Fertility Preservation Decision Aid in Parents and Adolescents and Young Adults (CAYA) Cancer Survivors

Launched by MURDOCH CHILDRENS RESEARCH INSTITUTE · Mar 19, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a special tool designed to help parents and young adults who have survived cancer understand their options for preserving fertility, which is the ability to have children in the future. Sometimes, when patients go through cancer treatment, they may lose the ability to have children later in life. This trial aims to see if using a fertility preservation decision aid (FP DA), along with regular information from healthcare providers, can better meet the needs of parents and young cancer survivors when it comes to making decisions about fertility.

To be eligible for this study, parents must be guardians of cancer survivors who were 25 years old or younger when diagnosed and have completed their cancer treatment. Young adults aged 16 and older who have survived cancer and are no longer receiving treatment can also join. Participants will receive information and support to help them understand their fertility options better. It's important to note that the study is not yet recruiting participants, and some individuals currently undergoing treatment or in palliative care, as well as certain minors, will not be eligible to participate. This trial could be a valuable opportunity for families to gain clarity about fertility options after cancer treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Inclusion Criteria for both parents and survivors:
• • Be able to communicate in English.
• • Signed written informed consent form.
• Inclusion Criteria for parents only:
• • • Parents/guardians of CAYA survivors who were ≤25 years (2) when diagnosed with cancer and have completed curative gonadotoxic treatment
• • Inclusion Criteria for survivors only
• • CAYA cancer survivors aged 16 years or over who have completed curative gonadotoxic treatment.
• • Participants can be on long-term adjuvant or endocrine therapy.
• • Participants may have achieved a pregnancy or livebirth.
• Exclusion Criteria:
• Exclusion Criteria for both parents and survivors:
• • CAYA patients currently undergoing cancer treatment and their parents/guardians.
• • CAYA patients who are palliative and their parents/guardians
• • A family member already in the study.
• Exclusion Criteria for survivors only:
• • • Minors who are not deemed to be mature minors as per protocol